Pfizer ends COVID-19 vaccine trial with a 95% success rate
Pfizer Inc PFE.N and BioNTech BNTX.O could secure emergency U.S. and European authorization for their COVID-19 vaccine next month
top of page
BUSINESS NEWS
INDIA NEWS
BAY AREA NEWS
bottom of page